Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

被引：0

作者：

G. Emerens Wensink

Marloes A. G. Elferink

Anne M. May

Linda Mol

Patricia A. H. Hamers

Sandra D. Bakker

Geert-Jan Creemers

Jan Willem B. de Groot

Gerty J. de Klerk

Brigitte C. M. Haberkorn

Annebeth W. Haringhuizen

Ronald Hoekstra

J. Cornelis B. Hunting

Emile D. Kerver

Danielle Mathijssen-van Stein

Marco B. Polée

Johannes F. M. Pruijt

Patricia Quarles van Ufford-Mannesse

Sandra Radema

Ronald C. Rietbroek

Lieke H. J. Simkens

Bea C. Tanis

Daan ten Bokkel Huinink

Manuel L. R. Tjin-A-Ton

Cathrien S. Tromp-van Driel

Monique M. Troost

Agnes J. van de Wouw

Franchette W. P. J. van den Berkmortel

Anke J. M. van der Pas

Ankie M. T. van der Velden

Marjan A. van Dijk

Joyce M. van Dodewaard-de Jong

Edith B. van Druten

Theo van Voorthuizen

Gerrit Jan Veldhuis

Henk M. W. Verheul

Hanneke J. H. M. J. Vestjens

Jeroen Vincent

Onno W. Kranenburg

Cornelis J. A. Punt

Geraldine R. Vink

Jeanine M. L. Roodhart

Miriam Koopman

机构：

[1] University Medical Center Utrecht,Department of Medical Oncology

[2] Utrecht University,Department of Research

[3] Netherlands Comprehensive Cancer Organisation,Julius Center for Health Sciences and Primary Care

[4] University Medical Center Utrecht,Department of Medical Oncology

[5] Utrecht University,Department of Medical Oncology

[6] Zaans Medical Center,Department of Medical Oncology

[7] Catharina Hospital,Department of Medical Oncology

[8] Isala Hospital,Department of Medical Oncology

[9] Spaarne Gasthuis,Department of Medical Oncology

[10] Maasstad Hospital,Department of Medical Oncology

[11] Hospital Gelderse Vallei,Department of Medical Oncology

[12] Ziekenhuisgroep Twente,Department of Medical Oncology

[13] St. Antonius Hospital,Department of Medical Oncology

[14] OLVG,Department of Medical Oncology

[15] Franciscus Gasthuis & Vlietland,Department of Medical Oncology

[16] Vlietlandplein,Department of Medical Oncology

[17] Medical Center Leeuwarden,Department of Medical Oncology

[18] Jeroen Bosch Hospital,Department of Medical Oncology

[19] HagaZiekenhuis,Department of Medical Oncology

[20] Radboud University Medical Center,Department of Medical Oncology

[21] Rode Kruis Hospital,Department of Medical Oncology

[22] Maxima Medical Center,Department of Medical Oncology

[23] Groene Hart Hospital,Department of Medical Oncology

[24] Diakonessenhuis Utrecht,Department of Medical Oncology

[25] Hospital Rivierenland,Department of Medical Oncology

[26] Gelre Hospital,Department of Medical Oncology

[27] Bravis Hospital Bergen op Zoom,Department of Medical Oncology

[28] VieCuri Medical Center,Department of Medical Oncology

[29] Zuyderland Medical Center Heerlen,Department of Medical Oncology

[30] LangeLand Hospital,Department of Medical Oncology

[31] Tergooi,Department of Medical Oncology

[32] ZorgSaam Hospital,Department of Medical Oncology

[33] Meander Medical Center,Department of Medical Oncology

[34] Reinier de Graaf Gasthuis,Department of Medical Oncology

[35] Hospital Rijnstate,Department of Medical Oncology

[36] Antonius Hospital Sneek,Department of Surgical Oncology

[37] Amsterdam University Medical Center,Utrecht Platform for Organoid Technology

[38] VU Medical Center,Department of Medical Oncology

[39] Elkerliek Hospital,undefined

[40] University Medical Center Utrecht,undefined

[41] Utrecht University,undefined

[42] University Medical Center Utrecht,undefined

[43] Utrecht University,undefined

[44] Amsterdam University Medical Centers,undefined

[45] University of Amsterdam,undefined

来源：

British Journal of Cancer | 2021年 / 124卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：399 / 406

页数：7

共 161 条

[1]

Venderbosch S(2014)Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies Clin. Cancer Res. 20 5322-5330

[2]

Nagtegaal ID(2016)The evolving role of microsatellite instability in colorectal cancer: a review Cancer Treat. Rev. 51 19-26

[3]

Maughan TS(2017)Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency Eur. J. Cancer 86 266-274

[4]

Smith CG(2016)Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers Br. J. Cancer 115 25-33

[5]

Cheadle JP(2019)Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: a population-based cohort of metastatic colorectal cancer patients Cancer Med. 8 3623-3635

[6]

Fisher D(2015)PD-1 blockade in tumors with mismatch-repair deficiency N. Engl. J. Med. 372 2509-2520

[7]

Gelsomino F(2017)Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Lancet 18 1182-1191

[8]

Barbolini M(2018)Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair–deficient/microsatellite instability–high metastatic colorectal cancer J. Clin. Oncol. 36 773-779

[9]

Spallanzani A(2017)Response to chemotherapy and prognosis in metastatic colorectal cancer with DNA deficient mismatch repair Clin. Colorectal Cancer 16 228-239

[10]

Pugliese G(2014)Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H) Ann. Oncol. 25 1032-1038

← 1 2 3 4 5 6 7 8 9 10 →